Clinical Distribution and Drug Resistance of Staphylococcus Aureus in Patients with Bloodstream Infection in Nanshan District People's Hospital
LI Gui-qiu
WEI Ying
LIAN Jie
WU Shao-yuan
PAN Wei-guang
Abstract：Objective To investigate the clinical distribution of Staphylococcus aureus and its antimicrobial resistance in patients with bloodstream infection and to provide evidence for the treatment and rational use of antimicrobial agents. MethodsFrom January 1st, 2016 to December 31st, 2016, a VITEK 2–compact automatic bacterial analyzer was used for bacterial identification and drug susceptibility test for clinically isolated bloodstream infections of Staphylococcus aureus. Results From January 1st, 2016 to December 31st, 2016, 87 strains of Staphylococcus aureus were isolated and distributed in various departments of the hospital, including ICU (22 ％), Orthopedics (11 ％), Cardiovascular Surgery (8 ％). The results showed that the resistance rate of penicillin G was 97.6％, the resistance rate of erythromycin was 78.2％, the resistance rate of clindamycin was 72.9 ％, ciprofloxacin, gentamicin resistant rate of about 25％, not isolated vancomycin, teicoplanin, quinuprine/dalfopristin, linezolid resistance strains. Conclusion Staphylococcus aureus isolated from blood cultures showed a high rate of resistance to penicillin G and erythromycin, multidrug resistance, no isolation of vancomycin–resistant Staphylococcus aureus.
Keywords：Staphylococcus aureusBloodstream infectionClinical distributionBacterial drug resistance
Publication Date：2018-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 10-12 )